The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver

Archives of Surgery

Volumn 131, Issue 7, 1996, Pages 703-707

  Lai, David T M ^a   Fulham, Michael ^a   Stephen, Michael S ^a   Chu, Kent Man ^a   Solomon, Michael ^a   Thompson, John F ^a   Sheldon, Donald M ^a   Storey, David W ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ANGIOGRAPHY; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COLON RESECTION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LIVER METASTASIS; LIVER RESECTION; LUNG METASTASIS; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PERCUTANEOUS BIOPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RETROPERITONEAL CANCER; THORAX RADIOGRAPHY;

EID: 0029900872     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430190025007     Document Type: Article

References (16)

1. Fortner JG, Silva JS, Golbey RB, Cox EB, MacLean BJ. Multi-variate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg. 1984;199:306-316.
2. August DA, Sugabaker PH, Ottow RT, Gianola FJ, Schneider PD. Hepatic resection of colorectal metastases: influence of clinical factors and adjuvant intraperitoneal 5-FU via Tenehkhoff catheter. Ann Surg. 1985;201:210-218.
3. Steele GJ, Ravikumar TS. Resection of hepatic metastases. Ann Surg. 1989; 210:127-138.
4. Hughes KS, Simon R, Songhorabodi S. Resection of the liver for colorectal carcinoma metastases: a multi-institutional study of long-term survivors. Surgery. 1988;103:278-288.
5. Gupta NC, Falk PM, Frank AL, Thorson AM, Frick MP, Bowman B. Preoperative staging of colorectal carcinoma using positron emission tomography. Nebr Med J. 1993;78:30-35.
6. Strauss LG, Clorius JH, Schlag P, et al. Recurrence of colorectal tumors: PET evaluation. Radiology. 1989;170:329-332.
7. Warburg O, Wind F, Negleis E. On the metabolism of tumours in the body. In: Warburg O, ed. The Metabolism of Tumors. London, England: Constable; 1930: 254-270.
8. Dahlbom M, Hoffman EJ, Hoh CK. Whole-body positron emission tomography, I: methods and performance characteristics. J Nucl Med. 1992;33:1191-1199.
9. Meikle SR, Bailey DL, Hooper PK, et al. Attenuation correction in whole body PET using simultaneous emission transmission scanning and accelerated EM reconstruction. J Nucl Med. 1995;36:1680-1689.
10. Solomon MJ, Stephen MS, White GH, Eyers AE. A new classification of hepatic territories using intraoperative ultrasound. Am J Surg. 1992;163:336-338.
11. Finlay IG, McArdle CS. Occult hepatic metastases in colorectal carcinoma. Br J Surg. 1986;73:732-735.
12. Glazer GM, Aisen AM, Francis IR. Evaluation of focal hepatic masses: a comparative study of MRI and CT. Gastrointest Radiol. 1986;11:263-268.
13. Ward BA, Miller DL, Frank JA, et al. Prospective evaluation of hepatic imaging studies in the detection of colorectal metastases: correlation with surgical findings. Surgery. 1989;105:180-187.
14. 18F]fluorodeoxyglucose in recurrent colorectal cancer. Br J Surg. 1994;81:1666-1670.
15. 18F-fluorodeoxyglucose positron emission tomography in pre-operative evaluation of lung cancer patients. Lancet. 1994;344:1265-1266.
16. Lowe VJ, Delong DM, Hoffman JM, et al. Optimum scanning protocol for FDG PET evaluation of pulmonary malignancy. J Nucl Med. 1995;36:883-887.